However, MMP-9 deficiency in mouse models led to increased interleukin-6 levels in the bone marrow, which promoted pancreatic ductal adenocarcinoma (PDAC) invasion and metastasis. Here, MMP9 is linked to pancreatic ductal adenocarcinoma.